Advertisement

Drug Abuse pp 77-103 | Cite as

Perspectives in Pharmacological Research on Drug Dependence

  • T. L. Chrusciel
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 20)

Abstract

The pharmacological problems connected with drug abuse and drug dependence constitute but one, albeit an important, part of the great complex of research and public health problems that arise in connection with drug taking for non-medical purposes.

Keywords

Biogenic Amine Early Warning System Drug Dependence Expert Committee Abuse Potential 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Cameron, D.C. Drug Dependence: some research issues. Bull. Wld Hlth Org., 1970, 43, 589–598.Google Scholar
  2. Collier, H. O. J. Supersensitivity and dependence. Nature, 220, 228–231, 1968.CrossRefGoogle Scholar
  3. Collier, H. O. J. Supersensitivity and dependence on cocaine. Nature, 220, 1327–1328, 1968.CrossRefGoogle Scholar
  4. Eddy, N.B., Halbach, H., Isbell, H. & Seevers, M.H. Drug dependence: its significance and characteristics. Bull. Wld Hlth Org., 1965, 32, 721–733.Google Scholar
  5. Eddy, N. B., Martin, W. R. Drug dependence of specific opiate antagonist type. Pharmakopsychiatrie, Neuropsychopharmakologie, 3, 73–82, 1970.CrossRefGoogle Scholar
  6. Ellingwood, E.H. “Accidental conditioning” with chronic methamphetamine intoxication: Implications for a theory of drug habituation. Psychopharmacologie, 21, 131–138, 1971.CrossRefGoogle Scholar
  7. Gill, E. W., Paton, W.D.M., & Pertweek, R.G. Preliminary experiments on the chemistry and pharmacology of cannabis. Nature, 228, 134–136, 1970.CrossRefGoogle Scholar
  8. Gunne, L. M. Personal communication, 1970.Google Scholar
  9. Martin, W. B. Pharmacological redundancy as an adaptive mechanism in the central nervous system. Fed. Proc., 29, 13–18, 1970.Google Scholar
  10. Smith, C.B. Effects of narcotic analgesic drugs on brain noradre-nergic mechanisms. Paper presented at the 2nd Pharmacological Society Symposium on Agonist and Antagonist Actions of Narcotic Analgesic Drugs, Aberdeen, 12-13 July, 1971.Google Scholar
  11. Wikler, A. Sites and mechanisms of actions of morphine and related drugs in the central nervous system. Pharmcol. Rev., 2, 435–503, 1970.Google Scholar
  12. World Health Organization. Treatment and care of drug addicts. Report of a Study Group. Wld Hlth Org. techn. Rep. Ser., no. 131, 1957.Google Scholar
  13. World Health Organization. Evaluation of dependence-producing drugs. Report of a WHO Scientific Group. Wld Hlth Org. techn. Rep. Ser., No. 287, 1964.Google Scholar
  14. World Health Organization. Services for the prevention and treatment of dependence on alcohol and other drugs. Fourteenth Report of the WHO Expert Committee on Mental Health. Wld Hlth Org. techn. Rep. Ser., No. 363, 1967.Google Scholar
  15. World Health Organization. Research in psychopharmacology. Reports of a WHO Scientific Group. Wld Hlth Org. techn. Rep. Ser., No. 371, 1967.Google Scholar
  16. World Health Organization. WHO Expert Committee on Drug Dependence. Sixteenth Report. Wld Hlth Org. techn. Rep. Ser., No. 407, 1969.Google Scholar
  17. World Health Organization. WHO Expert Committee on Drug Dependence. Eighteenth Report. Wld Hlth Org. techn. Rep. Ser., No. 460, 1970.Google Scholar

Copyright information

© Plenum Press, New York 1972

Authors and Affiliations

  • T. L. Chrusciel
    • 1
  1. 1.World Health OrganizationGenevaSwitzerland

Personalised recommendations